Sellers Dorsey Announces Leadership Transition: Kevin Seabaugh Steps into CEO Role
Sellers Dorsey has announced that Co-Founder and Chief Executive Officer, Martin Sellers, retired from his role on December 2, 2024. To succeed him, the Firm has named national healthcare innovation leader, Kevin Seabaugh, as the new Chief Executive Officer. Martin Sellers, who has led Sellers Dorsey since its founding in 2000, will transition to Executive Chairman of the Board, ensuring a continued focus on the firm's mission and future growth.
EDITORS' NOTE
With every Presidential Administration transition, change is certain to occur. The Sellers Dorsey Digest remains committed to providing subscribers with the industry's most current healthcare and Medicaid updates on a federal, state, and private sector level. While many media sources report on a variety of topics that may include predictions about what changes will occur with the new Presidential Administration, the Sellers Dorsey Digest stays true to its mission by providing current information from primary sources. Subscribers can feel confident that the Sellers Dorsey Digest is a source that helps stakeholders navigate change through information and education. We are grateful for your continued readership and look forward to bringing you the latest insights. Kind regards, Your Editors of the Sellers Dorsey Digest